Ind-Swift Limited (INDSWFTLTD)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
9.4
0.0(0.0%)

Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nutraceuticals, anti-diarrheal, anti-malarial, anti-depressants, cardiology, diabetology, neurology, and oncology. The company also provides contract research and manufacturing services. It serves government dispensaries, doctors, and hospitals through retailers, stockists, and carrying and forwarding channels. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India.

Pricing Updates

TODAY'S HIGH

9.6

TODAY'S LOW

9

52 WEEK HIGH

18.5

52 WEEK LOW

8.25

Major Holders

% of Shares Held by
All Insider

66.85%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

51.30 Cr.

ETERPRISE VALUE

1065.68 Cr.

NO. OF SHARES

5.41 Cr.

BOOK VALUE

-138.125

DIV. YIELD

0.4%

DEBT

1029.53 Cr.

GROSS PROFIT

188.21 Cr.

CASH

13.83 Cr.

REVENUE

412.45 Cr.

REVENUE/SHARE

76.179

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments01.60 Cr.1.60 Cr.1.60 Cr.
Change To Liabilities0000
Total cashflows from Investing Activities-18.41 Cr.-16.71 Cr.-11.35 Cr.-13.70 Cr.
Net Borrowings-24.13 Cr.-4.67 Lakhs5.94 Cr.-9.78 Cr.
Total Cash from Financing Activities-84.01 Cr.-48.29 Cr.-26.20 Cr.-13.03 Cr.
Other Liabilities21.95 Cr.50.04 Cr.25.20 Cr.16.94 Cr.
Total Assets0000
Net Income-20.02 Cr.-29.81 Cr.-19.12 Cr.8.19 Cr.
Change in Cash-12.80 Cr.12.23 Cr.-2.96 Cr.16.04 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities89.62 Cr.77.24 Cr.34.59 Cr.42.78 Cr.
Depreciation32.07 Cr.30.70 Cr.33.59 Cr.33.97 Cr.
Other Cashflows from Investing Activities1.06 Cr.1.81 Cr.1.01 Cr.28.48 Lakhs
Dividends Paid0000
Change to Inventory-6.73 Cr.-10.44 Cr.-3.40 Cr.-3.55 Cr.
Change to Account Receivables16.78 Cr.-15.91 Cr.-20.76 Cr.-10.98 Lakhs
Other Cashflows from Financing Activities-59.88 Cr.-48.25 Cr.-32.14 Cr.-3.25 Cr.
Change to Net Income45.56 Cr.50.67 Cr.19.09 Cr.-12.65 Cr.
Capital Expenditures-19.57 Cr.-20.21 Cr.-12.63 Cr.-14.02 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-19.60 Cr.-29.49 Cr.-16.66 Cr.8.19 Cr.
Minority InterestNoneNoneNoneNone
Net Income13.27 Cr.14.25 Cr.2.77 Cr.-16.57 Cr.
Selling General Administrative63.15 Cr.60.44 Cr.56.46 Cr.54.23 Cr.
Gross Profit186.69 Cr.170.93 Cr.146.31 Cr.131.21 Cr.
Ebit13.27 Cr.14.25 Cr.2.77 Cr.-16.57 Cr.
Operating Income13.27 Cr.14.25 Cr.2.77 Cr.-16.57 Cr.
Other Operating Expenses78.18 Cr.63.52 Cr.53.48 Cr.59.57 Cr.
Interest Expense-57.15 Cr.-51.45 Cr.-34.66 Cr.-3.47 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense41.79 Lakhs32.28 Lakhs2.46 Cr.0
Total Revenue397.71 Cr.359.66 Cr.336.87 Cr.295.16 Cr.
Total Operating Expenses384.43 Cr.345.40 Cr.334.09 Cr.311.73 Cr.
Cost of Revenue211.02 Cr.188.73 Cr.190.55 Cr.163.95 Cr.
Total Other Income Expense Net-32.87 Cr.-43.75 Cr.-19.43 Cr.24.76 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.-20.02 Cr.-29.81 Cr.-19.12 Cr.8.19 Cr.
Net Income Applicable to Common Shares-20.02 Cr.-29.81 Cr.-19.12 Cr.8.19 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets10.38 Cr.11.93 Cr.16.07 Cr.20.07 Cr.
Capital Surplus071.07 Cr.71.07 Cr.71.07 Cr.
Total Liabilities1352.07 Cr.1366.73 Cr.1314.76 Cr.1275.16 Cr.
Stock Holder Equity-720.32 Cr.-695.16 Cr.-713.11 Cr.-676.73 Cr.
Minority Interest0000
Other Liabilities85 Cr.82.34 Cr.41.16 Cr.40.13 Cr.
Total Assets631.75 Cr.671.57 Cr.601.64 Cr.598.42 Cr.
Common Stock10.83 Cr.10.83 Cr.10.83 Cr.10.83 Cr.
Retained Earnings0-807.66 Cr.-777.85 Cr.-758.73 Cr.
Other Liabilities15.19 Cr.16.21 Cr.16.24 Cr.14.62 Cr.
Good Will0000
Treasury Stock-731.15 Cr.30.59 Cr.-17.17 Cr.8.18 Lakhs
Other Assets80.45 Cr.147.46 Cr.99.88 Cr.110.42 Cr.
Cash16.18 Cr.28.99 Cr.16.75 Cr.19.72 Cr.
Current Liabilities717.59 Cr.706.16 Cr.654.12 Cr.615.86 Cr.
Long Term Asset Charges0000
Short Long Term Debt416.35 Cr.2.51 Cr.2.02 Cr.1.34 Cr.
Other Stockholder Equity-731.15 Cr.30.59 Cr.-17.17 Cr.8.18 Lakhs
Property Plant Equipment234.11 Cr.245.13 Cr.253.59 Cr.270.48 Cr.
Total Cur. Assets242.44 Cr.265.17 Cr.228.64 Cr.193.51 Cr.
Long Term Investments64.35 Cr.1.86 Cr.3.44 Cr.3.92 Cr.
Net Tangible Assets-730.70 Cr.-707.10 Cr.-729.18 Cr.-696.80 Cr.
Short Term Investments0000
Net Receivables90.62 Cr.107.94 Cr.94.16 Cr.75.56 Cr.
Long Term Debt619.29 Cr.644.16 Cr.644.21 Cr.644.67 Cr.
Inventory69.58 Cr.62.84 Cr.52.40 Cr.48.99 Cr.
Accounts Payable203.90 Cr.232.01 Cr.226.22 Cr.198.83 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account